Praised for superior 1-year returns (23%), higher dividend yield (0.7%), and diversified exposure across 377 holdings with potential for ground-floor opportunities in emerging growth companies. Offers broader risk distribution.
Presented as an alternative option with lower expense ratio (0.18%) but smaller asset base ($8.38 billion). No performance data or rating provided, making it a neutral comparison choice.
Outperformed on 1-year basis with 26.3% returns and 27% year-to-date gains. Offers better diversification across industrials and healthcare with lower volatility (max drawdown of 29.2% vs 32.7%), though higher expense ratio of 0.18%.
Recommended as the better buy with lower expense ratio (0.18%), higher dividend yield (0.77%), larger AUM ($8.3B), lower volatility (beta 1.02), and smoother 5-year performance with lower drawdown (-29.20%), despite slightly lower 1-year returns.
Articles that tag IJT but are mainly about other companies.
Presented as an alternative option with similar index tracking but higher expense ratio (0.18%) and lower assets ($8.11 billion) compared to VBK, making it a less attractive choice on a cost basis.
Articles and sentiment ratings from Massive / Polygon. Sentiment is the provider's model rating for this company, not Gainbot's view.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology